Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Diagnos Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by whippeton May 08, 2017 9:14am
157 Views
Post# 26215539

RE:ADK Shareprice... Marketcap Should ...

RE:ADK Shareprice... Marketcap Should ...
Hi Bob, 

this might be your biggest find in a long time.   It confirm that investing in ADK (an AI cie, with revenus, with contracts, involved in 15 countries, new applications being worked on our AI, 
the growing demand for our expertise, being in front of everybody in our field, now having enough cash to move forward, holding a major position in Cara (shortly Majescor), working on a US listing, more news releases in the pipeline, at .11- .12 price is a steal....  

I have a lot of confidence in Andre, and i believe we sould be much higher, without news.  
Also just to mention i am not scared of companies wanting to take us out cheap...  
We always have a choice to say no to a undervalued  takeout price.

Still very confident in ADK. 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities